Quantbot Technologies LP Has $8.36 Million Stock Holdings in Humana Inc. (NYSE:HUM)

Quantbot Technologies LP lifted its stake in Humana Inc. (NYSE:HUM) by 1.9% during the first quarter, HoldingsChannel reports. The fund owned 24,121 shares of the insurance provider’s stock after purchasing an additional 453 shares during the quarter. Humana comprises approximately 0.5% of Quantbot Technologies LP’s holdings, making the stock its 15th biggest position. Quantbot Technologies LP’s holdings in Humana were worth $8,363,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. First Financial Corp IN increased its stake in shares of Humana by 7.2% in the fourth quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock worth $157,000 after acquiring an additional 23 shares during the last quarter. Aurora Investment Counsel increased its position in Humana by 1.3% during the fourth quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock worth $1,155,000 after buying an additional 29 shares during the last quarter. Walker Financial Services Inc. increased its position in Humana by 3.9% during the fourth quarter. Walker Financial Services Inc. now owns 795 shares of the insurance provider’s stock worth $364,000 after buying an additional 30 shares during the last quarter. Signaturefd LLC increased its position in Humana by 1.2% during the fourth quarter. Signaturefd LLC now owns 2,634 shares of the insurance provider’s stock worth $1,206,000 after buying an additional 30 shares during the last quarter. Finally, Brighton Jones LLC increased its position in Humana by 6.8% during the fourth quarter. Brighton Jones LLC now owns 470 shares of the insurance provider’s stock worth $215,000 after buying an additional 30 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have commented on HUM. Royal Bank of Canada lowered their target price on shares of Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Piper Sandler began coverage on shares of Humana in a research report on Wednesday, June 26th. They set an “overweight” rating and a $392.00 target price on the stock. UBS Group lowered their target price on shares of Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Robert W. Baird initiated coverage on shares of Humana in a report on Thursday, May 30th. They set a “neutral” rating and a $374.00 price target for the company. Finally, Oppenheimer decreased their price target on shares of Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a report on Thursday, April 25th. Fourteen analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $409.55.

Humana Stock Performance

Shares of NYSE HUM traded up $2.49 during mid-day trading on Friday, hitting $382.22. The company had a trading volume of 1,049,371 shares, compared to its average volume of 1,772,646. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The business’s 50-day simple moving average is $354.15 and its 200-day simple moving average is $347.04. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The firm has a market cap of $46.06 billion, a P/E ratio of 23.64, a PEG ratio of 2.19 and a beta of 0.51.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The firm had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same quarter last year, the company earned $9.38 earnings per share. As a group, analysts predict that Humana Inc. will post 16.27 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.93%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio is 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.